Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOSELECT DANMARK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   1.4% 1.8% 1.9% 8.2% 1.8% 3.2% 16.1% 15.9%   Credit score (0-100)   79 73 70 28 71 54 11 12   Credit rating   A A A BB A BBB BB BB   Credit limit (kDKK)   29.3 3.3 1.0 0.0 2.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,131 1,956 348 -402 4,736 2,951 0.0 0.0   EBITDA   2,131 1,956 348 -1,307 1,960 -434 0.0 0.0   EBIT   1,773 1,578 4.3 -2,387 594 -1,544 0.0 0.0   Pre-tax profit (PTP)   1,736.1 1,577.2 -144.2 -2,642.8 320.7 -2,159.2 0.0 0.0   Net earnings   1,354.0 1,229.8 -112.5 -2,056.7 252.9 -1,726.1 0.0 0.0   Pre-tax profit without non-rec. items   1,736 1,577 -144 -2,643 321 -2,159 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   658 1,791 13,817 17,456 15,558 15,913 0.0 0.0   Shareholders equity total   3,673 4,103 3,491 1,434 1,687 -39.2 -239 -239   Interest-bearing liabilities   4,126 5,219 14,503 20,729 23,704 22,694 239 239   Balance sheet total (assets)   11,087 12,886 19,389 26,018 27,037 23,826 0.0 0.0   Net Debt   3,622 5,075 11,704 20,515 22,502 22,374 239 239     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,131 1,956 348 -402 4,736 2,951 0.0 0.0   Gross profit growth   -14.5% -8.2% -82.2% 0.0% 0.0% -37.7% -100.0% 0.0%   Employees   1 1 1 2 5 5 0 0   Employee growth %   0.0% 0.0% 0.0% 100.0% 150.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   11,087 12,886 19,389 26,018 27,037 23,826 0 0   Balance sheet change%   27.9% 16.2% 50.5% 34.2% 3.9% -11.9% -100.0% 0.0%   Added value   2,131.0 1,956.1 348.5 -1,306.7 1,675.1 -433.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,316 755 11,682 2,557 -3,263 -756 -15,913 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   83.2% 80.7% 1.2% 594.4% 12.5% -52.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.0% 13.2% 0.0% -10.5% 2.2% -6.1% 0.0% 0.0%   ROI %   24.6% 18.1% 0.0% -11.6% 2.5% -6.4% 0.0% 0.0%   ROE %   39.9% 31.6% -3.0% -83.5% 16.2% -13.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   33.1% 31.8% 18.0% 5.5% 6.2% -0.2% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   170.0% 259.4% 3,358.8% -1,570.0% 1,148.1% -5,157.0% 0.0% 0.0%   Gearing %   112.3% 127.2% 415.5% 1,445.5% 1,405.2% -57,918.6% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.1% 0.1% 1.5% 1.4% 1.2% 2.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.3 1.2 0.8 0.9 3.4 2.0 0.0 0.0   Current Ratio   1.4 1.3 1.0 2.4 8.9 6.0 0.0 0.0   Cash and cash equivalent   503.8 143.9 2,798.4 213.8 1,202.4 320.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,166.6 2,523.4 -154.0 4,995.9 10,189.9 6,594.8 -119.6 -119.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   2,131 1,956 348 -653 335 -87 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   2,131 1,956 348 -653 392 -87 0 0   EBIT / employee   1,773 1,578 4 -1,194 119 -309 0 0   Net earnings / employee   1,354 1,230 -112 -1,028 51 -345 0 0